Home › Voting trends
How shareholders voted in the 2026-2027 proxy season (July 2026 to June 2027), by the sector and size of the company: support for director elections, say on pay, auditor ratification, equity and pay plans and shareholder proposals, how funds voted against management, and where dissent was highest. Every figure is worked out from the companies’ own Form 8-K results and the funds’ Form N-PX filings.
The 2026-2027 season is in progress: it holds the meetings whose results have been filed so far, most of them outside the spring peak. Each change is measured against the same part of the 2025-2026 season (meetings up to the same day of the season), not the whole of it.
There are no company pages for 2026-2027 yet, so this season is read straight from the 8-K results on file. The funds’ Form N-PX filings for it are due by 31 August 2027, so the fund-vote and manager tables are empty, and the only shareholder proposals counted are those the 8-K itself describes as one.
By sectorBy company sizeShareholder proposals by topicManagers by topicHot spotsHow this is worked out
Median support for each type of ballot item, and the share of items at or past the site’s dissent line for that type, with the change from 2025-2026 in percentage points. Contested director elections are left out. A dash means too few items to show (fewer than 20 items or 5 companies). In each table, Items and Companies are counts; Median support is the support of the middle item in the row; the next column counts the row’s items at or past the dissent line (or, for shareholder proposals, passing), and % of items is that count as a percentage of the row’s own items. Change (pts) is in percentage points.
| Sector | Items | Companies | Median support | Change (pts) | Items 20%+ against or withheld | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Basic Materials | 41 | 7 | 98.6% | — | 1 | 2.4% | — |
| Consumer Discretionary | 630 | 99 | 98.1% | −0.1 | 39 | 6.2% | +2.6 |
| Consumer Staples | 133 | 19 | 98.0% | −0.3 | 12 | 9.0% | +6.2 |
| Energy | 17 | 4 | — | — | — | — | — |
| Finance | 309 | 58 | 94.9% | +0.5 | 48 | 15.5% | −5.7 |
| Health Care | 513 | 116 | 96.1% | −0.7 | 64 | 12.5% | +2.9 |
| Industrials | 304 | 56 | 97.9% | +0.7 | 13 | 4.3% | −0.2 |
| Miscellaneous | 49 | 10 | 94.7% | −2.4 | 5 | 10.2% | +2.3 |
| Real Estate | 108 | 19 | 96.2% | — | 15 | 13.9% | — |
| Technology | 449 | 85 | 97.0% | −0.8 | 38 | 8.5% | +5.3 |
| Telecommunications | 51 | 10 | 95.3% | −1.2 | 8 | 15.7% | +10.1 |
| Utilities | 23 | 5 | 96.3% | — | 1 | 4.3% | — |
| Unclassified | 31 | 17 | 99.4% | — | 2 | 6.5% | — |
| All companies | 2,658 | 505 | 97.2% | −0.3 | 247 | 9.3% | +3.4 |
| Sector | Items | Companies | Median support | Change (pts) | Items under 70% support | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Basic Materials | 3 | 3 | — | — | — | — | — |
| Consumer Discretionary | 68 | 65 | 95.8% | +1.8 | 4 | 5.9% | +4.0 |
| Consumer Staples | 16 | 16 | — | — | — | — | — |
| Energy | 4 | 4 | — | — | — | — | — |
| Finance | 24 | 24 | 96.2% | +2.2 | 3 | 12.5% | +3.0 |
| Health Care | 62 | 60 | 91.5% | +0.8 | 7 | 11.3% | −2.5 |
| Industrials | 41 | 41 | 96.4% | +0.4 | 1 | 2.4% | +2.4 |
| Miscellaneous | 7 | 7 | — | — | — | — | — |
| Real Estate | 6 | 6 | — | — | — | — | — |
| Technology | 53 | 53 | 92.9% | −1.4 | 6 | 11.3% | +4.7 |
| Telecommunications | 3 | 3 | — | — | — | — | — |
| Utilities | 1 | 1 | — | — | — | — | — |
| All companies | 288 | 283 | 95.0% | +0.9 | 27 | 9.4% | +4.6 |
| Sector | Items | Companies | Median support | Change (pts) | Items 15%+ against | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Basic Materials | 4 | 4 | — | — | — | — | — |
| Consumer Discretionary | 96 | 94 | 99.0% | +0.2 | 1 | 1.0% | +1.0 |
| Consumer Staples | 18 | 18 | — | — | — | — | — |
| Energy | 3 | 3 | — | — | — | — | — |
| Finance | 47 | 47 | 99.5% | — | 2 | 4.3% | — |
| Health Care | 115 | 112 | 98.7% | −0.4 | 5 | 4.3% | +4.3 |
| Industrials | 52 | 52 | 98.9% | −0.2 | 0 | 0.0% | 0.0 |
| Miscellaneous | 8 | 8 | — | — | — | — | — |
| Real Estate | 16 | 16 | — | — | — | — | — |
| Technology | 81 | 79 | 99.1% | +0.1 | 2 | 2.5% | +2.5 |
| Telecommunications | 9 | 9 | — | — | — | — | — |
| Utilities | 3 | 3 | — | — | — | — | — |
| Unclassified | 14 | 14 | — | — | — | — | — |
| All companies | 466 | 459 | 99.1% | +0.1 | 11 | 2.4% | +1.9 |
| Sector | Items | Companies | Median support | Change (pts) | Items 25%+ against | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Basic Materials | 4 | 2 | — | — | — | — | — |
| Consumer Discretionary | 30 | 28 | 95.4% | — | 4 | 13.3% | — |
| Consumer Staples | 3 | 3 | — | — | — | — | — |
| Energy | 2 | 2 | — | — | — | — | — |
| Finance | 17 | 13 | — | — | — | — | — |
| Health Care | 78 | 67 | 85.3% | — | 19 | 24.4% | — |
| Industrials | 16 | 14 | — | — | — | — | — |
| Miscellaneous | 2 | 2 | — | — | — | — | — |
| Real Estate | 4 | 4 | — | — | — | — | — |
| Technology | 30 | 26 | 93.7% | — | 6 | 20.0% | — |
| Telecommunications | 3 | 3 | — | — | — | — | — |
| Utilities | 3 | 3 | — | — | — | — | — |
| All companies | 192 | 167 | 91.8% | −2.5 | 36 | 18.8% | +6.7 |
| Sector | Items | Companies | Median support | Change (pts) | Items at its item type's line | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Basic Materials | 70 | 14 | 98.3% | — | 4 | 5.7% | — |
| Consumer Discretionary | 1,040 | 145 | 97.9% | 0.0 | 71 | 6.8% | +3.0 |
| Consumer Staples | 201 | 26 | 97.8% | −0.2 | 24 | 11.9% | +9.9 |
| Energy | 45 | 7 | 98.3% | +4.3 | 6 | 13.3% | +7.6 |
| Finance | 643 | 130 | 96.1% | +0.7 | 90 | 14.0% | −5.1 |
| Health Care | 1,155 | 187 | 95.2% | −1.2 | 205 | 17.7% | +6.0 |
| Industrials | 503 | 71 | 97.8% | +0.8 | 27 | 5.4% | −1.2 |
| Miscellaneous | 81 | 12 | 96.4% | −0.6 | 7 | 8.6% | +0.4 |
| Real Estate | 174 | 33 | 96.7% | −0.9 | 23 | 13.2% | +10.4 |
| Technology | 857 | 112 | 97.0% | −0.4 | 89 | 10.4% | +4.8 |
| Telecommunications | 79 | 11 | 95.8% | −0.9 | 11 | 13.9% | +9.8 |
| Utilities | 57 | 10 | 96.3% | — | 3 | 5.3% | — |
| Unclassified | 54 | 20 | 99.7% | — | 2 | 3.7% | — |
| All companies | 4,959 | 778 | 97.1% | −0.2 | 562 | 11.3% | +4.2 |
No Form N-PX fund votes are on file for 2026-2027.
Download: support by sector (CSV)
The same measures by market capitalisation: mega cap $200bn and over, large cap $10bn to $200bn, mid cap $2bn to $10bn, small cap $300m to $2bn, micro cap under $300m. Market values are as of 2026-11-08 and are applied to every season, so a company sits in one size group throughout.
| Company size | Items | Companies | Median support | Change (pts) | Items 20%+ against or withheld | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Mega cap$200bn and over | 31 | 3 | — | — | — | — | — |
| Large cap$10bn to $200bn | 385 | 46 | 98.2% | 0.0 | 12 | 3.1% | +0.7 |
| Mid cap$2bn to $10bn | 446 | 67 | 97.5% | −0.1 | 29 | 6.5% | +0.3 |
| Small cap$300m to $2bn | 404 | 77 | 97.8% | +1.2 | 27 | 6.7% | −0.4 |
| Micro capunder $300m | 1,072 | 239 | 96.0% | −1.4 | 157 | 14.6% | +5.9 |
| No market cap on filenot listed, or no price | 320 | 73 | 97.4% | +1.3 | 22 | 6.9% | −2.1 |
| All companies | 2,658 | 505 | 97.2% | −0.3 | 247 | 9.3% | +3.4 |
| Company size | Items | Companies | Median support | Change (pts) | Items under 70% support | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Mega cap$200bn and over | 2 | 2 | — | — | — | — | — |
| Large cap$10bn to $200bn | 43 | 41 | 93.6% | +0.6 | 4 | 9.3% | +3.4 |
| Mid cap$2bn to $10bn | 57 | 56 | 96.2% | +0.7 | 4 | 7.0% | +3.4 |
| Small cap$300m to $2bn | 54 | 53 | 97.7% | +3.0 | 2 | 3.7% | −2.2 |
| Micro capunder $300m | 113 | 112 | 91.3% | −2.7 | 13 | 11.5% | +8.6 |
| No market cap on filenot listed, or no price | 19 | 19 | — | — | — | — | — |
| All companies | 288 | 283 | 95.0% | +0.9 | 27 | 9.4% | +4.6 |
| Company size | Items | Companies | Median support | Change (pts) | Items 15%+ against | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Mega cap$200bn and over | 2 | 2 | — | — | — | — | — |
| Large cap$10bn to $200bn | 49 | 45 | 96.9% | −0.7 | 0 | 0.0% | 0.0 |
| Mid cap$2bn to $10bn | 68 | 66 | 99.3% | +0.3 | 0 | 0.0% | 0.0 |
| Small cap$300m to $2bn | 67 | 67 | 99.5% | +0.4 | 0 | 0.0% | 0.0 |
| Micro capunder $300m | 215 | 214 | 98.7% | −1.0 | 6 | 2.8% | −0.4 |
| No market cap on filenot listed, or no price | 65 | 65 | 99.6% | — | 5 | 7.7% | — |
| All companies | 466 | 459 | 99.1% | +0.1 | 11 | 2.4% | +1.9 |
| Company size | Items | Companies | Median support | Change (pts) | Items 25%+ against | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Large cap$10bn to $200bn | 6 | 4 | — | — | — | — | — |
| Mid cap$2bn to $10bn | 19 | 12 | — | — | — | — | — |
| Small cap$300m to $2bn | 22 | 20 | 92.2% | — | 3 | 13.6% | — |
| Micro capunder $300m | 120 | 110 | 89.3% | — | 27 | 22.5% | — |
| No market cap on filenot listed, or no price | 25 | 21 | 94.0% | — | 0 | 0.0% | — |
| All companies | 192 | 167 | 91.8% | −2.5 | 36 | 18.8% | +6.7 |
| Company size | Items | Companies | Median support | Change (pts) | Items at its item type's line | % of items | Change (pts) |
|---|---|---|---|---|---|---|---|
| Mega cap$200bn and over | 40 | 3 | — | — | — | — | — |
| Large cap$10bn to $200bn | 577 | 56 | 97.9% | 0.0 | 31 | 5.4% | +2.5 |
| Mid cap$2bn to $10bn | 686 | 89 | 97.6% | +0.2 | 47 | 6.9% | +0.4 |
| Small cap$300m to $2bn | 691 | 107 | 97.9% | +1.1 | 50 | 7.2% | −0.4 |
| Micro capunder $300m | 2,179 | 333 | 96.0% | −1.0 | 359 | 16.5% | +4.9 |
| No market cap on filenot listed, or no price | 786 | 190 | 97.2% | +0.9 | 74 | 9.4% | −3.0 |
| All companies | 4,959 | 778 | 97.1% | −0.2 | 562 | 11.3% | +4.2 |
No Form N-PX fund votes are on file for 2026-2027.
Download: support by company size (CSV)
Every season on file, so the trend reads across. Support is the share of votes cast; a proposal passes with more than 50%. Topics follow the site’s proposal labels.
| Topic | 2023-2024 | 2024-2025 | 2025-2026 | 2026-2027* |
|---|---|---|---|---|
| Climate & environment | 92 | 66 | 43 | 0 |
| Political spending & lobbying | 59 | 21 | 16 | 0 |
| Diversity & human capital | 95 | 69 | 47 | 2 |
| Human rights | 14 | 16 | 11 | 2 |
| Governance | 181 | 171 | 221 | 6 |
| Pay | 47 | 40 | 8 | 0 |
| Other | 106 | 82 | 74 | 16 |
| Topic | 2023-2024 | 2024-2025 | 2025-2026 | 2026-2027* |
|---|---|---|---|---|
| Climate & environment | 17.2% | 11.9% | 9.8% | — |
| Political spending & lobbying | 25.3% | 18.9% | — | — |
| Diversity & human capital | 15.4% | 6.4% | 1.8% | — |
| Human rights | — | — | — | — |
| Governance | 33.9% | 35.0% | 30.0% | — |
| Pay | 9.6% | 10.0% | — | — |
| Other | 11.0% | 9.9% | 8.8% | — |
| Topic | 2023-2024 | 2024-2025 | 2025-2026 | 2026-2027* |
|---|---|---|---|---|
| Climate & environment | 18.2% | 13.1% | 10.5% | — |
| Political spending & lobbying | 22.6% | 23.2% | — | — |
| Diversity & human capital | 15.8% | 8.2% | 4.6% | — |
| Human rights | — | — | — | — |
| Governance | 37.2% | 37.6% | 33.2% | — |
| Pay | 18.0% | 18.8% | — | — |
| Other | 12.9% | 12.4% | 15.7% | — |
| Topic | 2023-2024 | 2024-2025 | 2025-2026 | 2026-2027* |
|---|---|---|---|---|
| Climate & environment | 2 | 0 | 0 | 0 |
| Political spending & lobbying | 1 | 2 | 0 | 0 |
| Diversity & human capital | 0 | 0 | 0 | 0 |
| Human rights | 0 | 0 | 0 | 0 |
| Governance | 44 | 39 | 28 | 0 |
| Pay | 1 | 0 | 1 | 0 |
| Other | 1 | 1 | 5 | 3 |
* in progress. Seasons 2027 are read from 8-K filings only (see How this is worked out).
Download: shareholder proposals by topic (CSV)
The managers’ Form N-PX filings for 2026-2027 are not on file yet; they are due by 31 August 2027.
Where dissent was highest this season. “Share with dissent” is the share of management items at or past the dissent line for their type (directors 20%+ against, say on pay under 70%, plans 25%+ against, other board items 15%+ against).
| Sector | Management items | Companies | Share with dissent (% of items) | Median director support | Median say-on-pay support | Management items not approved | Shareholder proposals passing |
|---|---|---|---|---|---|---|---|
| Health Care | 1,155 | 187 | 17.7% | 96.1% | 91.5% | 14 | 0 |
| Finance | 643 | 131 | 14.0% | 94.9% | 96.2% | 1 | 1 |
| Telecommunications | 79 | 11 | 13.9% | 95.3% | 97.9% | 1 | 0 |
| Energy | 45 | 7 | 13.3% | 98.3% | 94.1% | 1 | 0 |
| Real Estate | 174 | 34 | 13.2% | 96.2% | 88.7% | 1 | 0 |
| Consumer Staples | 201 | 26 | 11.9% | 98.0% | 93.5% | 0 | 2 |
| Technology | 857 | 113 | 10.4% | 97.0% | 92.9% | 11 | 0 |
| Miscellaneous | 81 | 12 | 8.6% | 94.7% | 89.8% | 0 | 0 |
| Consumer Discretionary | 1,040 | 145 | 6.8% | 98.1% | 95.8% | 5 | 0 |
| Basic Materials | 70 | 14 | 5.7% | 98.6% | 98.3% | 0 | 0 |
| Industrials | 503 | 72 | 5.4% | 97.9% | 96.4% | 4 | 0 |
| Utilities | 57 | 10 | 5.3% | 96.3% | 90.2% | 0 | 0 |
| Unclassified | 54 | 23 | 3.7% | 99.4% | 0 | 0 |
The 25 industries (Nasdaq industry, or the SEC SIC description where Nasdaq has none) with the highest share of management items at or past the dissent line, among those with at least 20 items and 5 companies.
| Industry | Management items | Companies | Share with dissent (% of items) | Median director support | Management items not approved |
|---|---|---|---|---|---|
| Major Banks | 52 | 6 | 40.4% | 90.7% | 0 |
| Computer peripheral equipment | 51 | 5 | 33.3% | 74.4% | 0 |
| Savings Institutions | 21 | 6 | 33.3% | 83.6% | 0 |
| Services-Misc. Amusement & Recreation | 36 | 5 | 27.8% | 96.9% | 0 |
| Medical/Dental Instruments | 180 | 25 | 21.1% | 92.0% | 6 |
| Biotechnology: Biological Products (No Diagnostic Substances) | 130 | 26 | 20.0% | 99.0% | 0 |
| Biotechnology: Electromedical & Electrotherapeutic Apparatus | 50 | 8 | 20.0% | 95.0% | 0 |
| Finance: Consumer Services | 95 | 17 | 20.0% | 98.3% | 0 |
| Biotechnology: Pharmaceutical Preparations | 484 | 77 | 19.0% | 96.2% | 3 |
| Services-Prepackaged Software | 33 | 6 | 15.2% | 95.7% | 1 |
| Metal Fabrications | 47 | 7 | 14.9% | 94.8% | 0 |
| Industrial Specialties | 71 | 8 | 14.1% | 97.8% | 1 |
| Other Consumer Services | 50 | 9 | 14.0% | 97.2% | 1 |
| Oil & Gas Production | 32 | 5 | 12.5% | 98.3% | 0 |
| Electrical Products | 75 | 9 | 12.0% | 94.4% | 0 |
| Blank Checks | 213 | 53 | 11.7% | 90.0% | 0 |
| Restaurants | 60 | 5 | 11.7% | 98.4% | 1 |
| Real Estate Investment Trusts | 148 | 28 | 11.5% | 97.0% | 1 |
| Industrial Machinery/Components | 192 | 28 | 10.9% | 96.2% | 0 |
| Computer Software: Prepackaged Software | 173 | 24 | 10.4% | 96.8% | 3 |
| Investment Managers | 31 | 6 | 9.7% | 94.3% | 0 |
| Property-Casualty Insurers | 33 | 5 | 9.1% | 96.1% | 0 |
| Real Estate | 44 | 6 | 9.1% | 91.8% | 1 |
| Pharmaceutical Preparations | 35 | 9 | 8.6% | 99.7% | 2 |
| Semiconductors | 108 | 14 | 7.4% | 96.8% | 0 |
The company's lowest-supported nominee in an uncontested election. The first 25 of 505.
| # | Company | Sector | Size | Support | Nominee |
|---|---|---|---|---|---|
| 1 | Linkhome Holdings Inc. | Finance | Micro cap | 2% | Elect Director: Leung Tsz Kan |
| 2 | BlackSky Technology Inc. | Technology | Small cap | 21% | Elect Director: Susan Gordon |
| 3 | REGIS CORP. | Consumer Discretionary | Micro cap | 25% | Elect Director: Lockie Andrews |
| 4 | METHODE ELECTRONICS INC. | Technology | Small cap | 25% | Elect Director: David P. Blom |
| 5 | SkyAI, Inc. | Health Care | Micro cap | 25% | Elect Director: Soren Bo Christiansen |
| 6 | HILLTOP HOLDINGS INC. | Finance | Mid cap | 32% | Elect Director: J. Taylor Crandall |
| 7 | INVO Fertility, Inc. | Health Care | Micro cap | 34% | Elect Director: Trent Davis |
| 8 | SANFILIPPO JOHN B & SON INC | Consumer Staples | Small cap | 39% | Elect Director: Mercedes Romero |
| 9 | CEL SCI CORP | Health Care | Micro cap | 43% | Elect Director: Robert Watson |
| 10 | IRIDEX CORP. | Health Care | Micro cap | 43% | Elect Director: Scott Shuda |
| 11 | CONSUMER PORTFOLIO SERVICES INC. | Finance | Micro cap | 44% | Elect Director: Stephen H. Deckoff |
| 12 | REGIONAL HEALTH PROPERTIES INC. | Real Estate | No market cap on file | 45% | Elect Director: Steven J. Baileys |
| 13 | RCI HOSPITALITY HOLDINGS INC. | Consumer Discretionary | Micro cap | 46.3% | Elect Director: Yura Barabash |
| 14 | ENNIS INC. | Consumer Discretionary | Small cap | 47.9% | Elect Director: Michael D. Magill |
| 15 | PALATIN TECHNOLOGIES INC | Health Care | Micro cap | 49.5% | Elect Director: John K. A. Prendergast, Ph.D. |
| 16 | EQUUS TOTAL RETURN INC. | Finance | Micro cap | 49.8% | Elect Director: Kenneth I. Denos |
| 17 | SCHOLASTIC CORP. | Consumer Discretionary | Small cap | 50.2% | Elect Director: James W. Barge |
| 18 | ACTELIS NETWORKS INC | Telecommunications | No market cap on file | 50.5% | Elect Director: Julie Kunstler |
| 19 | MIND TECHNOLOGY INC. | Industrials | Micro cap | 51.3% | Elect Director: Peter H. Blum |
| 20 | FOCUS UNIVERSAL INC. | Industrials | Micro cap | 52.0% | Elect Director: Michael Pope |
| 21 | Polar Power, Inc. | Miscellaneous | Micro cap | 52.4% | Elect Director: Jim Ahern |
| 22 | TECHPRECISION CORP. | Industrials | Micro cap | 56% | Elect Director: Walter M. Schenker |
| 23 | IMMERSION CORP. | Technology | Micro cap | 57% | Elect Director: Elias Nader |
| 24 | INTRUSION INC. | Telecommunications | Micro cap | 58% | Elect Director: Gregory K. Wilson |
| 25 | LIFEVANTAGE CORP. | Health Care | Micro cap | 58% | Elect Director: Mr. Darwin K. Lewis |
The company's say-on-pay vote, lowest support first. The first 25 of 283.
| # | Company | Sector | Size | Support | Outcome |
|---|---|---|---|---|---|
| 1 | GEN DIGITAL INC. | Technology | Large cap | 41% | Not approved |
| 2 | Apogee Therapeutics, Inc. | Health Care | No market cap on file | 42% | Not approved |
| 3 | CRINETICS PHARMACEUTICALS INC. | Health Care | No market cap on file | 43% | Not approved |
| 4 | AMC ENTERTAINMENT HOLDINGS INC. | Consumer Discretionary | Mid cap | 45.3% | |
| 5 | VAXART INC. | Health Care | No market cap on file | 47.0% | Not approved |
| 6 | CONAGRA BRANDS INC. | Consumer Staples | Mid cap | 50.8% | Approved |
| 7 | MIND TECHNOLOGY INC. | Industrials | Micro cap | 52.9% | |
| 8 | CEA INDUSTRIES INC. | Consumer Staples | Micro cap | 53.7% | |
| 9 | ROIVANT SCIENCES LTD. | Health Care | Large cap | 54.1% | Approved |
| 10 | IMMERSION CORP. | Technology | Micro cap | 54.1% | |
| 11 | BlackSky Technology Inc. | Technology | Small cap | 56% | Approved |
| 12 | DIGITAL TURBINE INC. | Miscellaneous | Small cap | 59% | Approved |
| 13 | AXOS FINANCIAL INC. | Finance | Mid cap | 61% | |
| 14 | ETHZilla Corporation | Finance | Micro cap | 61% | Approved |
| 15 | KEY TRONIC CORP. | Technology | Micro cap | 62% | Approved |
| 16 | Creative Media & Community Trust Corp | Real Estate | Micro cap | 62% | Approved |
| 17 | BIO KEY INTERNATIONAL INC | Technology | Micro cap | 64% | Approved |
| 18 | RIVERVIEW BANCORP INC. | Finance | Micro cap | 64% | Approved |
| 19 | PDS BIOTECHNOLOGY CORP. | Health Care | Micro cap | 65% | Approved |
| 20 | GEE GROUP INC. | Consumer Discretionary | Micro cap | 66% | Approved |
| 21 | Cellectar Biosciences, Inc. | Health Care | Micro cap | 67% | Approved |
| 22 | NIKE INC. | Consumer Discretionary | Large cap | 68% | |
| 23 | APPLIED DIGITAL CORP. | Technology | Mid cap | 68% | |
| 24 | ARCADIA BIOSCIENCES INC. | Energy | Micro cap | 69% | Approved |
| 25 | Co-Diagnostics, Inc. | Health Care | Micro cap | 69% | Approved |
Board proposals (and uncontested director elections) the company's 8-K reports as not approved or not elected. The first 25 of 32.
| # | Company | Sector | Size | Items | Items (support) |
|---|---|---|---|---|---|
| 1 | NEXGEL INC. | Health Care | Micro cap | 3 | 3. TO APPROVE THE REINCORPORATION OF THE COMPANY FROM THE STATE OF DELAWARE TO THE STATE OF NEVADA (46.7%); 4. TO APPROVE AN INCREASE IN THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK OF THE COMPANY FROM 25,000,000 TO 100,000,000 SHARES (86%); 5. TO APPROVE, AT THE DISCRETION OF THE BOARD OF DIRECTORS, A REVERSE STOCK SPLIT OF THE ISSUED AND OUTSTANDING SHARES OF COMMON STOCK AT A RATIO IN THE RANGE OF 1-FOR-2 TO 1-FOR-10 (78%) |
| 2 | DXC TECHNOLOGY COMPANY | Technology | Mid cap | 2 | 4. A term extension and an increase in the number of shares of common stock available for issuance under the amended and restated DXC Technology Company 2017 Omnibus Incentive Plan (42%); 4. A term extension and an increase in the number of shares of common stock available for issuance under the amended and restated DXC Technology Company 2017 Omnibus Incentive Plan (42%) |
| 3 | SPAR Group, Inc. | Consumer Discretionary | No market cap on file | 2 | 1. The Reverse Stock Split Proposal (34%); 2. The Adjournment Proposal: To approve one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split Proposal (the " A (35%) |
| 4 | SkyAI, Inc. | Health Care | Micro cap | 2 | 3. The Company's 2026 Equity Incentive Plan (18%); 4. The adjournment of the 2026 Annual Meeting to the extent there were insufficient proxies at the 2026 Annual Meeting to approve any one or more of the foregoing proposals (41%) |
| 5 | VERIFYME INC. | Technology | Micro cap | 2 | 6. To and conditioned upon the consummation of the Merger, an amendment to the Company's Amended and Restated Articles of Incorporation, to authorize a new form of capital stock called blockchain common stock in the amou (90%); 7. Subject to and conditioned upon the consummation of the Merger, an amendment to the Company's Amended and Restated Articles of Incorporation, to make an express election permitting the distributions that would otherwi (98%) |
| 6 | ACTELIS NETWORKS INC | Telecommunications | No market cap on file | 1 | 3. To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the authorized number of shares of the Company's Common Stock from 30,000,000 shares to 80,000,000 shares (50.5%) |
| 7 | Apogee Therapeutics, Inc. | Health Care | No market cap on file | 1 | 2. The Compensation Proposal To approve, on a non-binding, advisory basis, the compensation that will or may be paid, or become payable to, Apogee's named executive officers that is based on or otherwise relates to the M (42%) |
| 8 | Aptevo Therapeutics Inc. | Health Care | Micro cap | 1 | 1. Approval of the Company's Amended and Restated Certificate of Incorporation An amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to make certain technical and administrative cha (87%) |
| 9 | CATALYST PHARMACEUTICALS INC. | Health Care | No market cap on file | 1 | 2. The Compensation Proposal To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Catalyst's named executive officers that is based on or otherwise relates to the Merger an (31%) |
| 10 | CLOUDASTRUCTURE, INC. | Technology | Micro cap | 1 | (3) The proposal to amend the Company's Certificate of Incorporation to decrease its total number of the authorized shares of capital stock from 500,000,000 shares to 83,333,334 shares, consisting of 69,000,000 shares of (95%) |
| 11 | CRINETICS PHARMACEUTICALS INC. | Health Care | No market cap on file | 1 | 2. To consider and vote on the proposal to approve, by non-binding, advisory vote, compensation that will or may be paid or become payable to Crinetics' named executive officers that is based on or otherwise relates to t (43%) |
| 12 | Cyclerion Therapeutics, Inc. | Health Care | Small cap | 1 | 4. To approve (A) the redomestication of the Company from the Commonwealth of Massachusetts to the Cayman Islands by domestication and (B)(i) the redomestication of the Company from the Commonwealth of Massachusetts to t (62%) |
| 13 | Empery Digital Inc. | Industrials | Micro cap | 1 | 2. Approval of Empery Digital Inc (43%) |
| 14 | FARADAY FUTURE INTELLIGENT ELECTRIC INC. | Industrials | Micro cap | 1 | 2. Name Change Proposal (67%) |
| 15 | FRIEDMAN INDUSTRIES INC. | Industrials | Micro cap | 1 | The number of the shares of Common Stock represented at the meeting that were voted for, voted against, or abstained from voting on the amendment to the Company's Articles of Incorporation to allow shareholders the abili (99%) |
| 16 | GEN DIGITAL INC. | Technology | Large cap | 1 | 3. Advisory vote to approve the Company's executive compensation (41%) |
| 17 | HEALTH CATALYST INC. | Technology | Micro cap | 1 | 4. To Approve the Restatement of the Company's Amended and Restated Certificate of Incorporation to Phase Out the Classified Board Structure (99.2%) |
| 18 | HEARTBEAM INC. | Health Care | Micro cap | 1 | 3. Proposal to amend the 2022 Equity Incentive Plan to increase the number of authorized shares by 3,000,000 shares (34%) |
| 19 | HELIX ENERGY SOLUTIONS GROUP INC. | Energy | Small cap | 1 | 10. Corporate Opportunities Provision (45%) |
| 20 | LIVERAMP HOLDINGS INC. | Technology | No market cap on file | 1 | 7. Merger Compensation Proposal (14%) |
| 21 | Lifeward Ltd. | Health Care | Micro cap | 1 | 6. To approve the renewal of the Company's Compensation Policy for officers and directors for a period of three years, as described in the Proxy Statement (49.0%) |
| 22 | Linkhome Holdings Inc. | Finance | Micro cap | 1 | Elect Director: Leung Tsz Kan (2%) |
| 23 | MY SIZE INC. | Technology | Micro cap | 1 | 4. Approval of an amendment to the Charter to authorize the issuance of blank check preferred stock (the "Blank Check Preferred Stock Proposal") (90%) |
| 24 | Moleculin Biotech, Inc. | Health Care | Micro cap | 1 | 5. Approve an Amendment to the Company ' s Amended and Restated Certificate of Incorporation to Eliminate Supermajority Voting Requirements to Amend the Amended and Restated Certificate of Incorporation - An amendment to (76%) |
| 25 | REGIS CORP. | Consumer Discretionary | Micro cap | 1 | Under the Company's majority voting policy, a director nominee must tender a conditional offer of resignation subject to acceptance or rejection by the Company's board of directors in the event the director does not rece (31%) |
Shareholder proposals with more than 50% of the votes cast. 3 companies.
| # | Company | Sector | Size | Items | Items (support) |
|---|---|---|---|---|---|
| 1 | CENTRAL PLAINS BANCSHARES, INC. | Finance | Micro cap | 1 | 3. The approval of a stockholder proposal with respect to the repurchase of shares of the Company's common stock (84%) |
| 2 | CONAGRA BRANDS INC. | Consumer Staples | Mid cap | 1 | 4. Shareholder Proposal to Limit Board Authority to Issue " Blank-Check " Preferred Stock (62%) |
| 3 | GENERAL MILLS INC. | Consumer Staples | Large cap | 1 | 6. Shareholder Proposal – Restriction On "Blank-check" Preferred Stock (64%) |
Download: hot spots (CSV)